Amir Gross, CEO, Cardiovalve

Amir Gross is the co-founder and CEO of CardioValve. Before co-founding and managing CardioValve, Amir founded and led Valtech Cardio in 2005 until its acquisition by Edwards Life Sciences (NYSE: EW).

Here is a summary of our conversation:

01:30                        Amir shares how the pandemic gave him more time with his family 

03:30                        How does a lawyer end up in the world of MedTech and cardiology?

05:50                        the story of the founding of Valtech. 

07:38                        what is structural heart disease and what problems, challenges are there to meet in the field?

10:00                        Are you seeing any impact or any change in the Cardiovascular market, due to the entry of digital health devices? 

13:00                        Amir shares about his investments as an angel investor and areas of interest.

15:30                        Why is a company’s image so important even in the early stages?

19:00                        What are some tips that you can give about managing stakeholder relationships – externally and internally and how to make sure that they're part of your journey as a CEO?

23:00                        Do you have a moonshot and what is it for you personally and for the cardio space? What would be, a dream, change or technology that you would see coming 10 years from now?

24:30                        Amir shares “the why” - We're doing it for patients, we're doing it for humanity. 

26:55                        What are your 2, 3 biggest pieces of advice to an entrepreneur at the beginning of their journey and how to best prepare.

29:40                        If you could go back to your 16-year-old self and tell yourself one thing. What would that be?

31:25                        When are we going to hear a next substantial milestone for Cardiovalve?